2015 Persian Gulf Criteria for Early Diagnosis of Behcet’s Disease
[1]
Iraj Salehi-Abari, Rheumatology Research Center, Amir Alam Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Behcet’s disease (BD) is a chronic inflammatory multisystem disorder belongs to the vasculitides characterized by oral aphthosis, genital aphthosis, ocular inflammation, skin lesions and vascular involvement. Behcet’s disease typically affects young adults 20 to 40 years of age with no significant difference in gender. Oral aphthosis is classically recurrent and it can be multiple or major but less likely persistent. Genital aphthosis in men and external genital aphthosis in women can be replaced by scar after improvement. Ocular inflammation is including anterior uveitis, intermediate/posterior uveitis and retinal vasculitis. Skin lesions are including pseudofolliculitis, erythema nodosum, acneiform lesions, pustular lesions, pyoderma gangrenosum, dermal aphthosis, superficial thrombophlebitis and so on. Vascular involvements are including vasculitis of small, medium and large sized vessels, arterial and venous type. Hemorrhage, stenosis and especially aneurysm formation and thrombosis are all of the vascular features of this disorder. Initial presentations of BD are commonly Oral aphthosis, Genital aphthosis and eye lesions and sometimes skin lesions and articular involvement. There are 16 sets of classification criteria for this disease including International Study Group (ISG, 1990) criteria, International Criteria for Behcet’s Disease (ICBD, 2006), ICBD revised (ITR-ICBD, 2013) and etc., but we don’t have any criteria for early diagnosis of it. In this letter the corresponding author wants to deliver Persian Gulf criteria for early diagnosis of BD.
Behcet's Disease, ISG Criteria, ICBD Criteria, ICBD Revised Criteria, Persian Gulf Criteria
[1]
Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M, et al. Behcet's disease in Iran: analysis of 6500 cases. International Journal of Rheumatic Diseases. 2010; 13(4): 367-73.
[2]
Yurdakul S, Hamuryudan V, Yazici H. Behcet syndrome. CurrOpinRheumatol. 2004; 16(1): 38-42.
[3]
Yazici H, Fresko I, Yurdakul S. Behcet's syndrome: disease manifestations, management, and advances in treatment. Nat ClinPractRheumatol. 2007; 3(3): 148-55.
[4]
Calamia KT, Wilson FC, Icen M, Crowson CS, Gabriel SE, Kremers HM. Epidemiology and clinical characteristics of Behcet's disease in the US: a population-based study. Arthritis Rheum. 2009 15; 61(5): 600-4.
[5]
O'Duffy JD. Behcet's disease. Curr Opin Rheumatol. 1994; 6(1): 39-43.
[6]
Kaklamani VG, Vaiopoulos G, Markomichelakis N, Kaklamanis P. Recurrent epididymo-orchitis in patients with Behcet's disease. J Urol. 2000 Feb; 163(2): 487-9.
[7]
Cho YH, Jung J, Lee KH, Bang D, Lee ES, Lee S. Clinical features of patients with Behcet's disease and epididymitis. J Urol. 2003; 170(4 Pt 1): 1231-3.
[8]
Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Altunbas HH, Urgancioglu M. Uveitis in Behcet disease: An analysis of 880 patients. Am J Ophthalmol. 2004; 138(3): 373-80.
[9]
Diri E, Mat C, Hamuryudan V, Yurdakul S, Hizli N, Yazici H. Papulopustular skin lesions are seen more frequently in patients with Behcet's syndrome who have arthritis: a controlled and masked study. Annals of the Rheumatic Diseases. 2001; 60(11): 1074-6.
[10]
Tunc R, Keyman E, Melikoglu M, Fresko I, Yazici H. Target organ associations in Turkish patients with Behcet's disease: a cross sectional study by exploratory factor analysis. J Rheumatol. 2002; 29(11): 2393-6.
[11]
Hatemi G, Bahar H, Uysal S, Mat C, Gogus F, Masatlioglu S, et al. The pustular skin lesions in Behcet's syndrome are not sterile. Ann Rheum Dis. 2004; 63(11): 1450-2.
[12]
Koc Y, Gullu I, Akpek G, Akpolat T, Kansu E, Kiraz S, et al. Vascular involvement in Behcet's disease. J Rheumatol. 1992; 19(3): 402-10.
[13]
Calamia KT, Schirmer M, Melikoglu M. Major vessel involvement in Behcet disease. Curr Opin Rheumatol. 2005; 17(1): 1-8.
[14]
Fei Y, Li X, Lin S, Song X, Wu Q, Zhu Y, et al. Major vascular involvement in Behcet's disease: a retrospective study of 796 patients. ClinRheumatol. 2013; 32(6): 845-52.
[15]
Kim HA, Choi KW, Song YW. Arthropathy in Behcet's disease. Scand J Rheumatol. 1997; 26(2): 125-9.
[16]
Maghraoui AE, Tabache F, Bezza A, Abouzahir A, Ghafir D, Ohayon V, et al. A controlled study of sacroiliitis in Behcet's disease. Clin Rheumatol. 2001; 20(3): 189-91.
[17]
Jung YS, Cheon JH, Park SJ, Hong SP, Kim TI, Kim WH. Clinical course of intestinal Behcet's disease during the first five years. Dig Dis Sci. 2013; 58(2): 496-503.
[18]
Al-Araji A, Kidd DP. Neuro-Behcet's disease: epidemiology, clinical characteristics, and management. Lancet Neurol. 2009;8(2):192-204.
[19]
Kalra S, Silman A, Akman-Demir G, Bohlega S, Borhani-Haghighi A, Constantinescu CS, et al. Diagnosis and management of Neuro-Behcet's disease: international consensus recommendations. J Neurol. 2014; 261(9): 1662-76.
[20]
Davatchi F, Sadeghi Abdollahi B, Chams-Davatchi C, Shahram F, Ghodsi Z, Nadji A, et al. Impact of the positive pathergy test on the performance of classification/diagnosis criteria for Behcet's disease. Mod Rheumatol. 2013; 23(1): 125-32.
[21]
Davatchi F. Diagnosis/Classification Criteria for Behcet's Disease. Patholog Res Int. 2012; 2012: 607921.
[22]
Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet. 1990; 335: 1078-80
[23]
Davatchi F, Schirmer M, Zouboulis C, et al. on behalf of the International Team for the Revision of the International Study Group Criteria for Bechet's disease. Evaluation and Revision of the International Study Group Criteria for Behcet's disease. Proceedings of the American College of Rheumatology Meeting; November 2007; Boston, MA. Abstract 1233.
[24]
Davatchi F, Assaad-Khalil S, Calamia KT, et al. The International Criteria for Behcet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol. 2014; 28(3): 338-47.
